Introduction: MedsFacts provides
MD-approved analysis to help both patients and physicians accurately research
and assess the risk-reward trade off for more than 20,000 different
pharmaceutical products. The below report offers compiled information from Food
& Drug Administration, social media, and MedsFacts user submissions. Between
January 2004 and October 2012, 1 individuals taking CARDIOMAGNIL reported
TREATMENT FAILURE to the FDA. A total of 7 CARDIOMAGNIL drug adverse event
reaction reports were made with the FDA during this time period. Often the FDA
only receives reports of the most critical and severe cases; these numbers may
therefore underrepresent the complication rate of the medication.
Topics covered: This page is designed
to help you determine the relationship, if any, between CARDIOMAGNIL and
TREATMENT FAILURE. In doing so, we compare CARDIOMAGNIL with other drugs that
cause TREATMENT FAILURE, to help you evaluate whether or not CARDIOMAGNIL causes
TREATMENT FAILURE. Likewise, this page shows the most highly-reported side
effects of CARDIOMAGNIL, so you can see if TREATMENT FAILURE ranks among
CARDIOMAGNIL's most well-known side effects.
The Dashboard explained: The
Dashboard first shows general Summary Statistics for CARDIOMAGNIL and
TREATMENT FAILURE, such as the raw number and percentage of patients in FDA
reports who used CARDIOMAGNIL and developed TREATMENT FAILURE. Next, the
Dashboard lists the most common reasons (indications) why CARDIOMAGNIL was
prescribed for patients. We then display a pie-chart which shows, in aggregate,
what we believe represents general physician opinion of the safety of
CARDIOMAGNIL. This pie-chart summarizes, for all FDA reports covering
CARDIOMAGNIL, whether or not the treating physician felt CARDIOMAGNIL (versus
other drugs the patient was taking) was responsible for the adverse
side-effects. After the pie-chart, we itemize the most common side effects in
FDA studies covering CARDIOMAGNIL. You may click on any of these side effects to
learn more about them, in general, or specifically for CARDIOMAGNIL. Finally, we
identify the drugs most widely associated with CARDIOMAGNIL in FDA literature.
You may also click on any of these drugs to view it's dashboard.
Dashboard view of our research literature concerning CARDIOMAGNIL : |
|
|
Summary Statistics
Reports of CARDIOMAGNIL causing TREATMENT FAILURE: 1 Reports of any side effect of CARDIOMAGNIL : 7 Percentage of CARDIOMAGNIL patients where TREATMENT FAILURE is a reported side effect: 14.285714285714% FDA reports of any drug causing TREATMENT FAILURE : 1673 Average percentage for all medicated patients where TREATMENT FAILURE is reported as a complication: 0.010485376409658% |
Most frequent diagnoses/indications for prescribing
CARDIOMAGNIL:THROMBOSIS PROPHYLAXIS ( 6 patients )
( 0 patients ) |
|
Physician opinion on CARDIOMAGNIL as adverse event culprit:
(* global) |
Most common side effects for patients taking
CARDIOMAGNIL:
TOXIC SKIN ERUPTION (3 patients) DIARRHOEA (3 patients) CRANIAL NEUROPATHY (2 patients) ANGINA PECTORIS (1 patients) TREATMENT FAILURE (1 patients) OTITIS MEDIA (1 patients) MYOCARDIAL FIBROSIS (1 patients) DECREASED APPETITE (1 patients) CRANIAL NERVE DISORDER (1 patients) CORONARY ARTERY DISEASE (1 patients) |
|
Twitter feed for CARDIOMAGNIL - Pending/Beta
|
Drugs with high reportage of TREATMENT FAILURE:
FOSAMAX (190 patients) REMICADE (100 patients) HUMIRA (75 patients) METHOTREXATE (55 patients) PREDNISONE (54 patients) ASPIRIN (50 patients) CYCLOSPORINE (50 patients) CYCLOPHOSPHAMIDE (44 patients) DIGOXIN (44 patients) VANCOMYCIN (43 patients) |
Basic reports are available, free of charge, in PDF format and are suitable for scientific publication. Further data and analytics are available upon request. We are in the process of adding new features to our site, including Q&A interface for patients to speak with experts on medication. Check back with us again in the near future to see.
Copyright 2013 MedsFacts
info@medsfacts.com
Комментариев нет:
Отправить комментарий